Health
India’s Cadila to end late-stage trials of potential COVID-… – Thomson Reuters Foundation
HEALTH-CORONAVIRUS/INDIA-CADILA HEALTH (URGENT):India’s Cadila to end late-stage trials of potential COVID-19 vaccine in March
(Removes extraneous words from paragraph 1)
By Sumit Khanna
AHMEDABAD, India July 17 (Reuters) – India’s Zydus Cadila plans to complete late-stage trials for its potential coronavirus vaccine in March 2021 and could produce up to 100 million doses a year if trials are successful, Chairman Pankaj Patel told Reuters.
Cadila’s vaccine candidate, dubbed ZyCov-D, is one of dozens being developed around the world to fight the coronavirus. (Writing by Zeba Siddiqui; Editing by Edmund Blair)
Our Sta…
-
Noosa News14 hours agoToombul Shopping Centre site thrown lifeline after Mirvac announces sale with ‘priority’ to build new retail centre
-
General14 hours agoAllegations against ex-Attorney-General Mark Dreyfus removed from Linda Reynolds action against Commonwealth
-
Noosa News16 hours agoMirvac to sell site to Irvine Group
-
General14 hours agoWoolworths executive was hospitalised by 100-hour-a-week workload, lawsuit claims